Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2013-06-18 18:42:39 UTC
Update Date2021-09-14 14:58:08 UTC
HMDB IDHMDB0060676
Secondary Accession Numbers
  • HMDB60676
Metabolite Identification
Common Name10-Hydroxycarbazepine
Description10-Hydroxycarbazepine, also known as GP 47779 or 10,11-MHD, belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. In humans, 10-hydroxycarbazepine is involved in the carbamazepine metabolism pathway. 10-Hydroxycarbazepine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 10-Hydroxycarbazepine.
Structure
Data?1563866090
Synonyms
ValueSource
10,11-Dihydro-10-hydroxycarbamazepineChEBI
10-HydroxycarbamazepineChEBI
GP 47779ChEBI
10-OH-CarbazepineHMDB
10,11-MHDMeSH
10,11-Dihydro-10-hydroxy-5H-dibenz(b,F)azepine-5-carboxamideMeSH
10-HydroxycarbazepineChEBI
Chemical FormulaC15H14N2O2
Average Molecular Weight254.2839
Monoisotopic Molecular Weight254.105527702
IUPAC Name9-hydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboxamide
Traditional Name9-hydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboxamide
CAS Registry NumberNot Available
SMILES
NC(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C12
InChI Identifier
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)
InChI KeyBMPDWHIDQYTSHX-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzazepines
Sub ClassDibenzazepines
Direct ParentDibenzazepines
Alternative Parents
Substituents
  • Dibenzazepine
  • Azepine
  • Benzenoid
  • Isourea
  • Secondary alcohol
  • Carboximidic acid derivative
  • Azacycle
  • Alcohol
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Imine
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.55 g/LALOGPS
logP1.26ALOGPS
logP1.73ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)14.1ChemAxon
pKa (Strongest Basic)-3.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area66.56 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity72.29 m³·mol⁻¹ChemAxon
Polarizability26.31 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+157.14931661259
DarkChem[M-H]-155.34631661259
DeepCCS[M-2H]-184.54730932474
DeepCCS[M+Na]+159.90230932474
AllCCS[M+H]+158.932859911
AllCCS[M+H-H2O]+154.932859911
AllCCS[M+NH4]+162.532859911
AllCCS[M+Na]+163.632859911
AllCCS[M-H]-161.532859911
AllCCS[M+Na-2H]-161.032859911
AllCCS[M+HCOO]-160.532859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.4.49 minutes32390414
Predicted by Siyang on May 30, 202210.4727 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.94 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1151.2 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid267.8 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid128.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid177.2 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid62.5 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid291.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid362.4 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)418.5 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid781.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid266.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1084.7 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid233.9 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid245.8 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate354.8 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA379.4 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water113.7 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
10-HydroxycarbazepineNC(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C123919.8Standard polar33892256
10-HydroxycarbazepineNC(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C122277.2Standard non polar33892256
10-HydroxycarbazepineNC(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C122468.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
10-Hydroxycarbazepine,1TMS,isomer #1C[Si](C)(C)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C212351.4Semi standard non polar33892256
10-Hydroxycarbazepine,1TMS,isomer #2C[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C212375.0Semi standard non polar33892256
10-Hydroxycarbazepine,2TMS,isomer #1C[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O[Si](C)(C)C)C2=CC=CC=C212366.2Semi standard non polar33892256
10-Hydroxycarbazepine,2TMS,isomer #1C[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O[Si](C)(C)C)C2=CC=CC=C212396.4Standard non polar33892256
10-Hydroxycarbazepine,2TMS,isomer #1C[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O[Si](C)(C)C)C2=CC=CC=C213076.8Standard polar33892256
10-Hydroxycarbazepine,2TMS,isomer #2C[Si](C)(C)N(C(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21)[Si](C)(C)C2491.6Semi standard non polar33892256
10-Hydroxycarbazepine,2TMS,isomer #2C[Si](C)(C)N(C(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21)[Si](C)(C)C2662.2Standard non polar33892256
10-Hydroxycarbazepine,2TMS,isomer #2C[Si](C)(C)N(C(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21)[Si](C)(C)C3182.7Standard polar33892256
10-Hydroxycarbazepine,3TMS,isomer #1C[Si](C)(C)OC1CC2=CC=CC=C2N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C2=CC=CC=C212458.6Semi standard non polar33892256
10-Hydroxycarbazepine,3TMS,isomer #1C[Si](C)(C)OC1CC2=CC=CC=C2N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C2=CC=CC=C212600.2Standard non polar33892256
10-Hydroxycarbazepine,3TMS,isomer #1C[Si](C)(C)OC1CC2=CC=CC=C2N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C2=CC=CC=C212939.7Standard polar33892256
10-Hydroxycarbazepine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C212586.3Semi standard non polar33892256
10-Hydroxycarbazepine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C212603.9Semi standard non polar33892256
10-Hydroxycarbazepine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212737.6Semi standard non polar33892256
10-Hydroxycarbazepine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212857.5Standard non polar33892256
10-Hydroxycarbazepine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2CC(O[Si](C)(C)C(C)(C)C)C2=CC=CC=C213238.9Standard polar33892256
10-Hydroxycarbazepine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21)[Si](C)(C)C(C)(C)C2888.4Semi standard non polar33892256
10-Hydroxycarbazepine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21)[Si](C)(C)C(C)(C)C3071.8Standard non polar33892256
10-Hydroxycarbazepine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C(=O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21)[Si](C)(C)C(C)(C)C3267.3Standard polar33892256
10-Hydroxycarbazepine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1CC2=CC=CC=C2N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=CC=CC=C213043.3Semi standard non polar33892256
10-Hydroxycarbazepine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1CC2=CC=CC=C2N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=CC=CC=C213213.1Standard non polar33892256
10-Hydroxycarbazepine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1CC2=CC=CC=C2N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=CC=CC=C213166.9Standard polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID102704
KEGG Compound IDC07493
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkLicarbazepine
METLIN IDNot Available
PubChem Compound114709
PDB IDNot Available
ChEBI ID701
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Wei CY, Chung WH, Huang HW, Chen YT, Hung SI: Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol. 2012 Jun;129(6):1562-9.e5. doi: 10.1016/j.jaci.2011.12.990. Epub 2012 Feb 8. [PubMed:22322005 ]
  2. Serralheiro A, Alves G, Fortuna A, Rocha M, Falcao A: First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 15;925:1-9. doi: 10.1016/j.jchromb.2013.02.026. Epub 2013 Feb 27. [PubMed:23507454 ]
  3. de Jesus Antunes N, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre V Jr, Takayanagui OM, Tozatto E, Lanchote VL: Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study. Chirality. 2013 Dec;25(12):897-903. doi: 10.1002/chir.22231. Epub 2013 Sep 30. [PubMed:24123382 ]
  4. Ferreira A, Rodrigues M, Oliveira P, Francisco J, Fortuna A, Rosado L, Rosado P, Falcao A, Alves G: Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Nov 15;971:20-9. doi: 10.1016/j.jchromb.2014.09.010. Epub 2014 Sep 16. [PubMed:25261836 ]
  5. Kim TH, Reid CA, Petrou S: Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy. Epilepsia. 2015 Jan;56(1):e6-9. doi: 10.1111/epi.12866. Epub 2014 Dec 8. [PubMed:25489632 ]